Methods

The Circulating Cell-free Genome Atlas (CCGA; NCT02889978) study was designed to determine whether cfDNA sequencing in combination with machine learning could detect cancer signals across multiple cancer types at sufficiently high specificity and predict the cancer signal origin (CSO) to be considered for a population-scale multi-cancer early detection (MCED) test. ................
................